Amphastar Pharmaceuticals, Inc. AMPH
Set alert
27.03 USD -0.69 -2.49%
At close · Nov 2
27.03 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
26.69 Day range 27.72
16.65 52-week range 29.52
- YTD
- +0.93%
- 1 year
- +6.00%
- Open
- 27.72
- Prev close
- 27.72
- Mkt cap
- 1.15B
- Vol
- 497.70K
- Avg vol
- 467.31K
- EPS
- 1.69
- P/E
- 15.99
- Div yield
- 0.00%
More statistics
- Low
- 26.69
- High
- 27.72
- Forward P/E
- 8.52
- Beta
- 0.94
- Short ratio
- 8.22
- Inst. own
- 68.48%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 24.76
- 200-d avg
- 22.25
- 1y target
- 22.50
MAX chart
Events in this range
- Aug 7, 2025Earnings: 0.85; estimate 0.71; surprise 19.72%
- Nov 6, 2025Earnings: 0.93; estimate 0.77; surprise 20.78%
- May 7, 2026Earnings: 0.42; estimate 0.7; surprise -40%
- Jun 3, 2026Rating: Barclays · Equal-Weight → Equal-Weight
- Aug 6, 2026Earnings: 0.91; estimate 0.62; surprise 46.77%
- Aug 7, 2026Rating: Wells Fargo · Equal-Weight → Equal-Weight
- Aug 7, 2026Rating: Piper Sandler · Neutral → Neutral
Signals (64)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Aug 1, 2026 | 3 months ago |
| SMA: Bearish | Feb 1, 2026 | 9 months ago |
| SMA: Bullish | Nov 1, 2025 | 1 year ago |
| SMA: Bearish | Sep 1, 2025 | 1 year ago |
| SMA: Bullish | Aug 1, 2025 | 1 year ago |
| SMA: Bearish | Dec 1, 2024 | 1 year ago |
| SMA: Bearish | Dec 1, 2024 | 1 year ago |
| SMA: Bullish | Aug 1, 2024 | 2 years ago |
| SMA: Bullish | Jul 1, 2024 | 2 years ago |
| SMA: Bearish | Jun 1, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 1, 2024 | 2 years ago |
| SMA: Bearish | Feb 1, 2024 | 2 years ago |
| RSI: Overbought | May 1, 2023 | 3 years ago |
| MACD: Buy Signal | Mar 1, 2023 | 3 years ago |
| SMA: Bullish | Feb 1, 2023 | 3 years ago |
| MACD: Sell Signal | Dec 1, 2022 | 3 years ago |
| SMA: Bearish | Aug 1, 2022 | 4 years ago |
| RSI: Overbought | Mar 1, 2022 | 4 years ago |
| SMA: Bullish | Nov 1, 2021 | 5 years ago |
Newest 20 of 64.
Analyst view
Consensus: hold
Hold
Price target (mean) 22.50 -16.8% downside
Now 27.03
- Target (low)
- 20.00
- Target (mean)
- 22.50
- Target (high)
- 30.00
Ratings (0m) 7 0 buy · 6 hold · 1 sell
- Strong buy0
- Buy0
- Hold6
- Sell0
- Strong sell1
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.85867 | 0.70 – 1.05 | 0.93 | -7.7% | 197.50M | +3.0% | 7 |
| Next quarter | 0.69 | 0.69 – 0.69 | 0.51 | +35.3% | 194.77M | +6.4% | 1 |
| Current year | 2.96 | 2.59 – 3.24 | 3.25 | -8.9% | 747.32M | +3.8% | 7 |
| Next year | 2.64 | 2.64 – 2.64 | 2.17 | +21.7% | 783.99M | +4.9% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 18, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Aug 7, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| Aug 7, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jun 29, 2026 | B of A Securities | Downgrade | Neutral | Underperform |
| Jun 3, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| May 14, 2026 | Wells Fargo | Downgrade | Overweight | Equal-Weight |
| May 11, 2026 | Piper Sandler | Reiterated | Neutral | Neutral |
| May 8, 2026 | Needham | Downgrade | Buy | Hold |
| Apr 21, 2026 | Jefferies | Downgrade | Buy | Hold |
| Apr 8, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Feb 27, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Feb 27, 2026 | Needham | Maintained | Buy | Buy |
| Dec 9, 2025 | Barclays | Initiated | — | Equal-Weight |
| Nov 7, 2025 | Needham | Maintained | Buy | Buy |
| Oct 22, 2025 | Needham | Reiterated | Buy | Buy |
| Aug 26, 2025 | B of A Securities | Maintained | Neutral | Neutral |
| Aug 12, 2025 | Needham | Upgrade | Hold | Buy |
| Aug 8, 2025 | Piper Sandler | Maintained | Neutral | Neutral |
| May 12, 2025 | JP Morgan | Downgrade | Overweight | Neutral |
| May 8, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Apr 10, 2025 | Needham | Reiterated | Hold | Hold |
| Mar 21, 2025 | Piper Sandler | Maintained | Neutral | Neutral |
| Feb 4, 2025 | Piper Sandler | Downgrade | Overweight | Neutral |
| Nov 22, 2024 | Wells Fargo | Initiated | — | Overweight |
| Aug 8, 2024 | Needham | Reiterated | — | Hold |
| Aug 8, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Jun 27, 2024 | Piper Sandler | Reiterated | Overweight | Overweight |
| May 22, 2024 | Needham | Reiterated | — | Hold |
| May 9, 2024 | Needham | Reiterated | — | Hold |
| Apr 10, 2024 | Needham | Reiterated | — | Hold |